392 related articles for article (PubMed ID: 23090560)
1. ACOG Practice Bulletin Number 131: Screening for cervical cancer.
Committee on Practice Bulletins—Gynecology
Obstet Gynecol; 2012 Nov; 120(5):1222-38. PubMed ID: 23090560
[TBL] [Abstract][Full Text] [Related]
2. Practice Bulletin No. 157: Cervical Cancer Screening and Prevention.
Obstet Gynecol; 2016 Jan; 127(1):e1-e20. PubMed ID: 26695583
[TBL] [Abstract][Full Text] [Related]
3. Practice Bulletin No. 157 Summary: Cervical Cancer Screening and Prevention.
Obstet Gynecol; 2016 Jan; 127(1):185-187. PubMed ID: 26695578
[TBL] [Abstract][Full Text] [Related]
4. Practice Bulletin No. 168: Cervical Cancer Screening and Prevention.
Obstet Gynecol; 2016 Oct; 128(4):e111-e130. PubMed ID: 27661651
[TBL] [Abstract][Full Text] [Related]
5. Practice Bulletin No. 168 Summary: Cervical Cancer Screening and Prevention.
Obstet Gynecol; 2016 Oct; 128(4):923-925. PubMed ID: 27661643
[TBL] [Abstract][Full Text] [Related]
6. Update on primary HPV screening for cervical cancer prevention.
Rizzo AE; Feldman S
Curr Probl Cancer; 2018 Sep; 42(5):507-520. PubMed ID: 30146348
[TBL] [Abstract][Full Text] [Related]
7. The ASCCP Cervical Cancer Screening Task Force Endorsement and Opinion on the American Cancer Society Updated Cervical Cancer Screening Guidelines.
Marcus JZ; Cason P; Downs LS; Einstein MH; Flowers L
J Low Genit Tract Dis; 2021 Jul; 25(3):187-191. PubMed ID: 34138787
[TBL] [Abstract][Full Text] [Related]
8. Optimal Cervical Cancer Screening in Women Vaccinated Against Human Papillomavirus.
Kim JJ; Burger EA; Sy S; Campos NG
J Natl Cancer Inst; 2017 Feb; 109(2):. PubMed ID: 27754955
[TBL] [Abstract][Full Text] [Related]
9. Making Sense of Cervical Cancer Screening Guidelines and Recommendations.
Davis M; Feldman S
Curr Treat Options Oncol; 2015 Dec; 16(12):55. PubMed ID: 26467929
[TBL] [Abstract][Full Text] [Related]
10. Cervical cancer screening among women who attend sexually transmitted diseases (STD) clinics: background paper for 2010 STD Treatment Guidelines.
Datta SD; Saraiya M
Clin Infect Dis; 2011 Dec; 53 Suppl 3():S153-9. PubMed ID: 22080268
[TBL] [Abstract][Full Text] [Related]
11. New cervical cancer screening guidelines, again.
Karjane N; Chelmow D
Obstet Gynecol Clin North Am; 2013 Jun; 40(2):211-23. PubMed ID: 23732026
[TBL] [Abstract][Full Text] [Related]
12. Testing for human papillomavirus in cervical cancer screening: a review of indications and methodology.
Nishino HT; Tambouret RH; Wilbur DC
Cancer Cytopathol; 2011 Aug; 119(4):219-27. PubMed ID: 21717588
[TBL] [Abstract][Full Text] [Related]
13. How will transitioning from cytology to HPV testing change the balance between the benefits and harms of cervical cancer screening? Estimates of the impact on cervical cancer, treatment rates and adverse obstetric outcomes in Australia, a high vaccination coverage country.
Velentzis LS; Caruana M; Simms KT; Lew JB; Shi JF; Saville M; Smith MA; Lord SJ; Tan J; Bateson D; Quinn M; Canfell K
Int J Cancer; 2017 Dec; 141(12):2410-2422. PubMed ID: 28801947
[TBL] [Abstract][Full Text] [Related]
14. Comparison of cervical cancer screening results among 256,648 women in multiple clinical practices.
Blatt AJ; Kennedy R; Luff RD; Austin RM; Rabin DS
Cancer Cytopathol; 2015 May; 123(5):282-8. PubMed ID: 25864682
[TBL] [Abstract][Full Text] [Related]
15. [Cervical cancer screning: from cytology to HPV testing].
Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2019 May; 54(5):289-292. PubMed ID: 31154708
[TBL] [Abstract][Full Text] [Related]
16. ACS/ASCCP/ASCP guidelines for the early detection of cervical cancer.
Fontaine PL; Saslow D; King VJ
Am Fam Physician; 2012 Sep; 86(6):501, 506-7. PubMed ID: 23062041
[No Abstract] [Full Text] [Related]
17. Relative Performance of HPV and Cytology Components of Cotesting in Cervical Screening.
Schiffman M; Kinney WK; Cheung LC; Gage JC; Fetterman B; Poitras NE; Lorey TS; Wentzensen N; Befano B; Schussler J; Katki HA; Castle PE
J Natl Cancer Inst; 2018 May; 110(5):501-508. PubMed ID: 29145648
[TBL] [Abstract][Full Text] [Related]
18. The latest recommendations from the USPSTF.
Campos-Outcalt D
J Fam Pract; 2012 May; 61(5):278-82. PubMed ID: 22577630
[TBL] [Abstract][Full Text] [Related]
19. Cervical cancer incidence in British Columbia: Predicting effects of changes from Pap to human papillomavirus screening and of changes in screening participation.
Coldman A; van Niekerk D; Smith L; Ogilvie G
J Med Screen; 2017 Dec; 24(4):195-200. PubMed ID: 27810984
[TBL] [Abstract][Full Text] [Related]
20. Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance.
Huh WK; Ault KA; Chelmow D; Davey DD; Goulart RA; Garcia FA; Kinney WK; Massad LS; Mayeaux EJ; Saslow D; Schiffman M; Wentzensen N; Lawson HW; Einstein MH
J Low Genit Tract Dis; 2015 Apr; 19(2):91-6. PubMed ID: 25574659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
